ClinicalTrials.Veeva

Menu

Intense Pulsed Light Therapy in Meibomian Gland Dysfunction

D

Dar Al Shifa Hospital

Status

Unknown

Conditions

Meibomian Gland Dysfunction

Treatments

Device: intense pulsed light

Study type

Interventional

Funder types

Other

Identifiers

NCT04904874
02282021065726

Details and patient eligibility

About

to evaluate the effect of intense pulsed light on resistant patients with Meibomian gland dysfunction

Enrollment

50 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age of at least 20 years.
  • The diagnosis of obstructive MGD based on ocular symptoms, plugged gland orifices, vascularity and irregularity of lid margins, and reduced meibum expression (meibum grade of .1, where grade 0 = clear meibum easily expressed, grade 1 = cloudy meibum expressed with mild pressure, grade 2 = cloudy meibum expressed with more than moderate pressure, and grade 3 = meibum could not be expressed even with strong pressure).
  • failure of at least 3 types of conventional MGD therapy to improve symptoms or objective findings for at least 1 year before study treatment

Exclusion criteria

  • the presence of active skin lesions, skin cancer, or other specific skin pathology.
  • active ocular infection or ocular inflammatory disease.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

flourescein staining, miboscore
Other group
Treatment:
Device: intense pulsed light

Trial contacts and locations

1

Loading...

Central trial contact

Magda Torky

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems